Stock SPHERIX INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Spherix Inc Nasdaq

Equities

US84842R3049

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Spherix Inc
Apr. 04 North American Morning Briefing : Focus Turns to -2- DJ
Apr. 01 Dominari Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Dominari Holdings Inc. is a holding company. The Company, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading and asset management. It operates through its wholly owned subsidiaries, including Dominari Financial Inc. (Dominari Financial) and Dominari Securities LLC (Dominari Securities). Dominari Securities offers and plans to offer a range of broker-dealer and registered investment adviser services. Its services include wealth management, investment banking, sales and trading, asset management and insurance products. Dominari Securities provides a comprehensive array of financial services to high-net-worth individuals and families, corporate executives, and public and private businesses. Dominari Securities also provides full-service brokerage, wealth planning and margin lending services. Dominari Securities’ investment banking division provides strategic advisory services and capital markets products to middle market businesses.

Sales per Business

USD in Million2022Weight2023Weight Delta
Dominari Financial
100.0 %
- - 2 100.0 % -

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
0 nan % 2 100.0 % -

Managers

Managers TitleAgeSince
Anthony Hayes CEO
 Chief Executive Officer 56 13-02-28
Kyle Wool PSD
 President - 21-04-11
George M. Way DFI
 Director of Finance/CFO - 23-04-02
Christopher Devall COO
 Chief Operating Officer - 22-06-30
Matthew McCullough LAW
 General Counsel - 23-04-30
Darrell Dotson LAW
 General Counsel - -

Members of the board

Members of the board TitleAgeSince
Tim Ledwick BRD
 Director/Board Member 66 15-07-08
Anthony Hayes CEO
 Chief Executive Officer 56 13-02-28
Gregory Blattner BRD
 Director/Board Member 47 18-05-02
Robert Dudley BRD
 Director/Board Member 70 20-04-16
Kyle Wool PSD
 President - 21-04-11
Soo Yu BRD
 Director/Board Member 53 22-06-06
Kyle Haug BRD
 Director/Board Member 41 Nov. 08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 3,825 0 0 67.33 %
Stock B 0 834 0 0
Stock C 1 5,995,065 4,039,690 ( 67.38 %) 0

Shareholders

NameEquities%Valuation
Anthony Hayes
6.263 %
334,754 6.263 % 820 147 $
Kyle Wool
5.125 %
273,931 5.125 % 671 131 $
Vanguard Group, Inc. (Subfiler)
3.618 %
193,392 3.618 % 473 810 $
George M. Way
1.802 %
96,311 1.802 % 235 962 $
BlackRock Institutional Trust Co. NA
1.408 %
75,275 1.408 % 184 424 $
Renaissance Technologies LLC
0.7619 %
40,726 0.7619 % 99 779 $
Geode Capital Management LLC
0.7339 %
39,229 0.7339 % 96 111 $
Dimensional Fund Advisors LP
0.6992 %
37,376 0.6992 % 91 571 $
Christopher Devall
0.5619 %
30,033 0.5619 % 73 581 $
Bridgeway Capital Management LLC
0.3835 %
20,500 0.3835 % 50 225 $
NameEquities%Valuation
Daniel W Armstrong
28.57 %
1,350 28.57 % 3 308 $
Charles Strogen
23.81 %
1,125 23.81 % 2 756 $
Francis Howard
19.05 %
900 19.05 % 2 205 $
Douglas R Armstrong
9.524 %
450 9.524 % 1 103 $
NameEquities%Valuation
Chai Lifeline, Inc.
100.00 %
834 100.00 % 2 043 $

Company contact information

Dominari Holdings, Inc.

725 5th Avenue 23rd floor

10022, New York

+703 992 9325

http://www.aikidopharma.com
address Spherix Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.67% 42.19B
LONZA GROUP AG Stock Lonza Group AG
+44.30% 40.15B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.31B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+6.55% 24.63B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.66% 18.2B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.96% 12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.57% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+16.03% 10.4B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-4.80% 9.94B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. DOMH Stock
  4. Stock
  5. Company Spherix Inc